Abstract | RATIONALE: Recent data suggest that dopamine (DA) D1-like receptor full agonists may be potential pharmacotherapeutic agents for treating cocaine abuse. The structurally novel isochroman D1-like agonist, A-77636, has not been well characterized and may prove to be useful as such an agent. OBJECTIVES: METHODS:
Drug-naive Swiss-Webster mice were pretreated with SKF 81297, SKF 82958 or A-77636 (1-10 mg/kg) and cocaine (5-56 mg/kg) prior to a 30-min period in which locomotor activity was assessed. Rats were trained on a fixed ratio 20 (FR20) schedule to discriminate IP saline from cocaine (10 mg/kg) injections. Cocaine alone (1-10 mg/kg) and with either A-77636 (0.56-1.7 mg/kg), SKF 82958 (0.01-0.1 mg/kg) or SKF 81297 (0.1-0.56) were injected IP 5 min prior to a 15-min test session. RESULTS:
Cocaine maximally stimulated activity at 20-40 mg/kg with higher and lower doses stimulating activity less. Each D1-like agonist produced a dose-related decrease in cocaine-induced locomotor activity and lowered its maximal rate. Each of the D1-like agonists partially substituted for cocaine, with maximal substitution approximating 49, 35, and 24% for SKF 81297, SKF 82958, and A-77636, respectively. SKF 82958 significantly shifted the cocaine dose-effect curve approximately 3-fold to the left. With SKF 81297, there was a trend towards a leftward shift of cocaine dose effects, however the change was not statistically significant. In contrast to the other two D1-like agonists, A-77636 either did not affect the cocaine dose-effect curve or shifted it to the right. CONCLUSIONS: All three agonists produced similar effects on cocaine-induced locomotor activity, however the discriminative-stimulus effects of cocaine were affected differently by the D1 agonists. These results suggest fundamental differences in the actions of these D1 agonists. Because A-77636 consistently attenuated the present effects of cocaine, it may prove more useful than the others as a pharmacotherapy to treat cocaine abuse.
|
Authors | Allison L Chausmer, Jonathan L Katz |
Journal | Psychopharmacology
(Psychopharmacology (Berl))
Vol. 159
Issue 2
Pg. 145-53
(Jan 2002)
ISSN: 0033-3158 [Print] Germany |
PMID | 11862342
(Publication Type: Comparative Study, Journal Article)
|
Chemical References |
- Benzazepines
- Benzopyrans
- Dopamine Agonists
- Dopamine Uptake Inhibitors
- Receptors, Dopamine D1
- A 77636
- SK&F 81297
- SK&F 82958
- Cocaine
- Adamantane
|
Topics |
- Adamantane
(analogs & derivatives, pharmacology)
- Animals
- Benzazepines
(pharmacology)
- Benzopyrans
(pharmacology)
- Cocaine
(pharmacology)
- Discrimination, Psychological
(drug effects, physiology)
- Dopamine Agonists
(pharmacology)
- Dopamine Uptake Inhibitors
(pharmacology)
- Dose-Response Relationship, Drug
- Drug Interactions
(physiology)
- Male
- Mice
- Motor Activity
(drug effects, physiology)
- Rats
- Rats, Sprague-Dawley
- Receptors, Dopamine D1
(agonists, physiology)
|